Reports for FRESENIUS KABI CANADA LTD
Company Name
FRESENIUS KABI CANADA LTD
Totals |
||
Shortage reports |
307 |
|
| Actual shortage: | 11 (4%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 5 (2%) | |
| Resolved: | 290 (94%) | |
Discontinuation Reports |
0 |
|
| To be discontinued: | 0 | |
| Discontinued: | 0 | |
| Reversed: | 0 | |
Late reports |
48 (16%) |
|
Overdue reports |
4 (33%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SODIUM ACETATE INJECTION, USP | 328MG | SOLUTION | Actual shortage | 2022-09-01 | 2022-09-02 | 168505 |
| SODIUM ACETATE INJECTION, USP | 328MG | SOLUTION | Actual shortage | 2023-06-01 | 2023-08-02 | 193516 |
| KETOROLAC TROMETHAMINE INJECTION, USP | 30MG | LIQUID | Resolved | 2019-01-08 | 2019-01-19 | 71575 |
| KETOROLAC TROMETHAMINE INJECTION, USP | 30MG | LIQUID | Resolved | 2019-01-22 | 2019-04-06 | 73209 |
| KETOROLAC TROMETHAMINE INJECTION, USP | 30MG | LIQUID | Resolved | 2023-06-14 | 2023-08-01 | 194929 |
| KETOROLAC TROMETHAMINE INJECTION, USP | 30MG | LIQUID | Resolved | 2024-01-31 | 2024-02-20 | 217938 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2mg/mL | Solution | Resolved | 2018-06-06 | 2018-10-02 | 51677 |
| MITOXANTRONE INJECTION | 2MG | SOLUTION | Resolved | 2020-04-20 | 2020-05-06 | 112481 |
| LINEZOLID INJECTION | 2MG | SOLUTION | Resolved | 2019-04-10 | 2019-07-05 | 81157 |
| LINEZOLID INJECTION | 2MG | SOLUTION | Resolved | 2019-08-02 | 2019-09-14 | 90630 |
| LINEZOLID INJECTION | 2MG | SOLUTION | Resolved | 2022-04-20 | 2022-06-27 | 159027 |
| LINEZOLID INJECTION | 2MG | SOLUTION | Resolved | 2022-06-27 | 2022-11-02 | 163524 |
| LINEZOLID INJECTION | 2MG | SOLUTION | Resolved | 2024-03-19 | 2024-04-22 | 222722 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2019-07-26 | 2020-01-16 | 90057 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2020-04-07 | 2020-04-25 | 111239 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2020-12-09 | 2021-01-22 | 129882 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2021-03-26 | 2022-01-31 | 136445 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2021-03-26 | 2022-04-13 | 136448 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Avoided shortage | 2022-04-13 | 2022-07-15 | 158783 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2022-04-13 | 2022-07-15 | 158786 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0